SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending due to a mixed earnings report, with a Q4 beat overshadowed by a weaker-than-expected Q1 outlook, leading to a significant immediate share price pullback. The community is actively debating whether this represents an overreaction and a buying opportunity or reflects deeper competitive challenges and a lengthy turnaround for its foundry business. This discussion highlights the ongoing scrutiny of Intel's position within the rapidly evolving semiconductor landscape.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is seeing substantial market activity and trending status, fueled by widespread community speculation regarding a potential buyout or partnership with a major pharmaceutical firm. This intense conversation, alongside its Breakthrough Therapy Designation for MASH, positions the stock within a highly competitive and attractive biopharmaceutical sector. Investors are actively discussing the possibility of a significant short squeeze and a substantial re-evaluation of the company's valuation.

Ascent Solar Technologies, Inc. engages in the design, development, and manufacture of solar technology and power solutions for remote locations and extreme environments. It integrates photovoltaic modules into a variety of applications such as aerospace, defense, transportation, and electronic products. The company was founded by Mohan S. Misra and Joseph H. Armstrong on October 18, 2005 and is headquartered in Thornton, CO.

Ascent Solar Technologies Inc

Ascent Solar Technologies is currently trending amid widespread speculation that its lightweight, flexible solar technology is poised for critical roles in the expanding space sector, particularly for advanced orbital applications. Community discussions highlight enthusiasm following insights from influential figures about the future of space-based AI data centers and defense projects, alongside persistent chatter about high short interest and potential for significant moves. Traders are actively debating the company's strategic partnerships and its historical volatility, seeking clarity on future prospects.

Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD.

Sensei Biotherapeutics Inc

Sensei Biotherapeutics ($SNSE) is trending following its announced strategic review, which includes discontinuing lead drug development and exploring options such as a sale or merger, despite ongoing concerns about its ability to continue as a going concern. Community discussion highlights the stock's low float and substantial cash reserves, fueling widespread speculation about a potential short squeeze and ambitious price targets, although some express caution about pump-and-dump activity.

BitGo Holdings Inc. - Ordinary Shares - Class A

BitGo is trending following its NYSE debut as the first crypto IPO of the year, opening above its initial offering price. Community discussion is split, with some anticipating a significant run due to its large assets under management and high revenue growth, while others are wary of its initial volatility and drawing comparisons to past struggling crypto debuts amidst broader market conditions.

Spotify Technology SA engages in the provision of digital music services. It operates through the Premium and Ad-Supported segments. The Premium segment provides subscribers with online and offline streaming access of music and podcasts on computers, tablets, and mobile devices. The Ad-Supported segment offers users with limited on-demand online access of music and unlimited online access of podcasts on computers, tablets, and mobile and smart devices. The company was founded by Daniel Ek and Martin Lorentzon on December 27, 2006 and is headquartered in Luxembourg.

Spotify Technology S.A.

Spotify is actively discussed following analyst upgrades citing its AI initiatives and pricing power, coinciding with recent premium subscription price increases and the introduction of new AI-powered features and music videos. While these developments spark optimism for future revenue growth and user engagement, the community remains divided on subscriber retention post-hikes, and frustrated by the stock's tendency to mirror Netflix's movements.

Movano, Inc. is a health-focused technology company. The firm uses non-invasive technology to enable individuals and their healthcare partners to measure and manage their health conditions. It offers solutions through the app, the cloud, the wearable, and the sensor. The company was founded by Michael Aaron Leabman in January 2018 and is headquartered in Pleasanton, CA.

Movano Inc

Movano Inc. is trending after its merger partner, Corvex, announced a long-term NVIDIA H200 GPU deployment, sparking significant community discussion. Many are anticipating a substantial upside due to the NVIDIA association and the stock's low float, while others express caution regarding its history of volatility and potential dilution from the merger terms.

Spring Valley Acquisition Corp. III is a blank check company. It was created for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on March 12, 2025 an is headquartered in Dallas, TX.

Spring Valley Acquisition Corp III - Ordinary Shares - Class A

SVAC is trending following its definitive agreement to merge with General Fusion, which is poised to become the first publicly traded pure-play fusion energy company. The community is buzzing with excitement over this long-term play, highlighting the significant backing from investors like Jeff Bezos and drawing comparisons to other successful energy SPACs. Strong interest is noted in both the common shares and warrants, with many anticipating substantial future upside.

RYVYL Inc. is a financial technology company that develops software platforms and tools that are focused on providing global payment acceptance and disbursement capabilities. It offers an innovative payment platform-as-a-service that redefines global payment solutions, enabling seamless business-to-business, consumer-to-business, and peer-to-peer transactions worldwide. The company leverages advanced electronic payment technology to deliver seamless financial solutions across global markets. It operates through two geographical segments: North America and International. The company was founded on April 10, 2007 and is headquartered in San Diego, CA.

Ryvyl Inc

Ryvyl Inc. is gaining significant attention amid its pending merger with Roundtable, which aims to create a Web3 digital media platform leveraging a Bitcoin treasury. The community is actively discussing the recent reverse stock split and anticipated Nasdaq compliance, with many anticipating a potential short squeeze due to the extremely low public float. This confluence of developments in fintech and digital media is driving high conversation around the stock's future valuation and momentum.

Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics, and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Roche Holding AG - ADR

Roche Holdings AG ADR

Roche Holdings is generating significant buzz from both strategic acquisitions and ongoing shareholder disputes. The company's recent aggressive moves into the obesity and MASH markets, coupled with promising clinical updates across its oncology and neurology pipelines, highlight its strategic growth. Simultaneously, community discussions are heavily focused on calls for accountability regarding the low-value acquisition of LumiraDx assets, sparking a contentious debate among investors.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
